Latest Breaking News On - Paul beisswenger - Page 1 : comparemela.com

New study validates predictive biomarkers in diabetic kidney disease, an important step in precision medicine

NaviDKD™ proactive screening technology for kidney health from Journey Biosciences confirmed in type 2 diabetes population. LEBANON, N.H., May 3, .

Paul beisswengerAdam graybillGeisel school of medicine at dartmouthVeterans affairs diabetes trialJourney biosciences incPrnewswire journey biosciences incJourney biosciencesDiabetes careControl cardiovascular riskBiosciences founderChief scientific officerProfessor emeritusGeisel schoolJourney bioscience

New study validates predictive biomarkers in diabetic kidney disease, an important step in precision medicine

/PRNewswire/ Journey Biosciences, Inc. A new study recently published in the journal Diabetes Care continues to validate the role that specific biomarkers -.

Paul beisswengerAdam graybillGeisel school of medicine at dartmouthJourney biosciences incJourney biosciencesProfessor emeritusGeisel schoolJourney bioscience

Journey Biosciences appoints Greg Dooley and Gordie Nye to its board of directors

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Mexico cityDistrito federalUnited statesGreg dooleyPaul beisswengerGordie nyeAdam graybillGeisel school of medicine at dartmouthJourney biosciences incPrnewswire journey biosciences incGoodyear tire rubber company in akronVice president financeLatin americaGoodyear tireRubber companyDooley family

Journey Biosciences announces company launch and introduction of its NaviDKD diagnostic screening technology to prevent and manage high risk kidney complications associated with Diabetes

Journey Biosciences announces company launch and introduction of its NaviDKD diagnostic screening technology to prevent and manage high risk kidney complications associated with Diabetes
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesPaul beisswengerAdam graybillGeisel school of medicine at dartmouthJourney biosciences incChief executive officerJourney biosciencesGeisel schoolJourney bioscience

Journey Biosciences announces company launch and introduction of its NaviDKD diagnostic screening technology to prevent and manage high risk kidney complications associated with Diabetes

United statesPaul beisswengerAdam graybillGeisel school of medicine at dartmouthJourney biosciences incChief executive officerJourney biosciencesGeisel schoolJourney bioscience